Skip to Main Content

Author Details

Jeffrey S Morris
Perelman School of Medicine, University of Pennsylvania
1999
192
58
PMIDPaper TitleJournal TitlePublished Year
37467732Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma.Oncology2023
37467732Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma.Oncology2023
34059508Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer.Gut2022
36276070Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma.Front Oncol2022
35996397Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development.J Hepatocell Carcinoma2022
34059508Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer.Gut2022
36276070Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma.Front Oncol2022
35996397Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development.J Hepatocell Carcinoma2022
32931023HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk.Hepatology2021
33963589Rejoinder.Stat Med2021
33963579AIDS and COVID: A tale of two pandemics and the role of statisticians.Stat Med2021
34117863Methylation-eQTL analysis in cancer research.Bioinformatics2021
33472672COVID-TRACK: world and USA SARS-COV-2 testing and COVID-19 tracking.BioData Min2021
34111531Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal Cancer.J Am Coll Surg2021
33889299Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib.Oncotarget2021
33564777International Comparisons of Harmonized Laboratory Value Trajectories to Predict Severe COVID-19: Leveraging the 4CE Collaborative Across 342 Hospitals and 6 Countries: A Retrospective Cohort Study.medRxiv2021
33512440Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios.JAMA Pediatr2021
32931023HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk.Hepatology2021
33109741Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting.Clin Cancer Res2021
33414133ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer.Clin Cancer Res2021
34762658Proliferation, apoptosis and their regulatory protein expression in colorectal adenomas and serrated lesions.PLoS One2021
34527608A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by <sup>90</sup>Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma.J Hepatocell Carcinoma2021
33512440Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios.JAMA Pediatr2021
33564777International Comparisons of Harmonized Laboratory Value Trajectories to Predict Severe COVID-19: Leveraging the 4CE Collaborative Across 342 Hospitals and 6 Countries: A Retrospective Cohort Study.medRxiv2021
33889299Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib.Oncotarget2021
34527608A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by <sup>90</sup>Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma.J Hepatocell Carcinoma2021
34762658Proliferation, apoptosis and their regulatory protein expression in colorectal adenomas and serrated lesions.PLoS One2021
33963589Rejoinder.Stat Med2021
33963579AIDS and COVID: A tale of two pandemics and the role of statisticians.Stat Med2021
34117863Methylation-eQTL analysis in cancer research.Bioinformatics2021
34111531Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal Cancer.J Am Coll Surg2021
33109741Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting.Clin Cancer Res2021
33472672COVID-TRACK: world and USA SARS-COV-2 testing and COVID-19 tracking.BioData Min2021
33414133ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer.Clin Cancer Res2021
32492113Intra-Subject Variability and Diurnal Cycle of Ocular Perfusion Pressure as Characterized by Continuous Telemetry in Nonhuman Primates.Invest Ophthalmol Vis Sci2020
32152150Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis.Cancer Res2020
32492113Intra-Subject Variability and Diurnal Cycle of Ocular Perfusion Pressure as Characterized by Continuous Telemetry in Nonhuman Primates.Invest Ophthalmol Vis Sci2020
33262420Comparison of extraocular and intraocular pressure transducers for measurement of transient intraocular pressure fluctuations using continuous wireless telemetry.Sci Rep2020
32762545Characteristics of pediatric patients with traumatic epidural hematomas who can be safely observed: a clinical validation study.Br J Radiol2020
32984091Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study.J Hepatocell Carcinoma2020
32981991Quantile Function on Scalar Regression Analysis for Distributional Data.J Am Stat Assoc2020
33027788Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients.Oncology2020
33415011KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations.Am J Cancer Res2020
33027788Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients.Oncology2020
33415011KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations.Am J Cancer Res2020
33262420Comparison of extraocular and intraocular pressure transducers for measurement of transient intraocular pressure fluctuations using continuous wireless telemetry.Sci Rep2020
32762545Characteristics of pediatric patients with traumatic epidural hematomas who can be safely observed: a clinical validation study.Br J Radiol2020
32984091Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study.J Hepatocell Carcinoma2020
32981991Quantile Function on Scalar Regression Analysis for Distributional Data.J Am Stat Assoc2020
32152150Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis.Cancer Res2020
  • 1 - 50 of 384

Recommended Authors

Christine B Peterson
University of Texas MD Anderson Cancer Center
Career Start Year 2013
Number of shared co-authors 15
Osvaldo Espin-Garcia
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 0
Eunjee Lee
Chungnam National University
Career Start Year 2007
Number of shared co-authors 8
Jennifer Clarke
Department of Food Science and Technology, University of Nebraska-Lincoln
Career Start Year 2006
Number of shared co-authors 0
Marco Chierici
Fondazione Bruno Kessler
Career Start Year 2006
Number of shared co-authors 0
Kouros Owzar
Duke University
Career Start Year 2005
Number of shared co-authors 2
Guanghua Xiao
The University of Texas Southwestern Medical Center
Career Start Year 2005
Number of shared co-authors 8
Mengling Liu
NYU Grossman School of Medicine
Career Start Year 2005
Number of shared co-authors 0
Richard A Moffitt
Stony Brook University, and Stony Brook Cancer Center
Career Start Year 2005
Number of shared co-authors 2
Nathalie Pochet
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 0
Jiang Gui
Geisel School of Medicine at Dartmouth
Career Start Year 2004
Number of shared co-authors 4
Qi Long
and Informatics Perelman School of Medicine, University of Pennsylvania
Career Start Year 2003
Number of shared co-authors 2
Minya Pu
University of California
Career Start Year 2003
Number of shared co-authors 0
May D Wang
Georgia Institute of Technology
Career Start Year 2003
Number of shared co-authors 1
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
J??rg Rahnenf??hrer
TU Dortmund University
Career Start Year 2002
Number of shared co-authors 1
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 6
Keyue Ding
Queen's University
Career Start Year 2002
Number of shared co-authors 0
Jean Yee Hwa Yang
The University of Sydney
Career Start Year 2001
Number of shared co-authors 1
Mark A van de Wiel
Amsterdam University Medical Centers (Amsterdam UMC)
Career Start Year 2001
Number of shared co-authors 1
Heidi Spratt
University of Texas Medical Branch
Career Start Year 2001
Number of shared co-authors 7
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 1
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 2
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 1
Russell D Wolfinger
SAS Institute
Career Start Year 1994
Number of shared co-authors 2
Wei Xu
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 1
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 4
Yudi Pawitan
Karolinska Institute
Career Start Year 1988
Number of shared co-authors 7
David M Rocke
University of California davis
Career Start Year 1983
Number of shared co-authors 1
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 21

Collaborators

Scott Kopetz
University of Texas MD Anderson Cancer Center
Co-authored papers 28
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Co-authored papers 20
Kevin R Coombes
Medical College of Georgia
Co-authored papers 16
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Co-authored papers 8
Scott M Lippman
Moores Cancer Center, university of california san diego
Co-authored papers 8
J Crawford Downs
University of Alabama at Birmingham
Co-authored papers 7
Christopher A Girkin
Heersink School of Medicine, University of Alabama-Birmingham
Co-authored papers 6
Qingyi Wei
South China University of Technology
Co-authored papers 6
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 6
Jean-Pierre J Issa
Fels Cancer Institute for Personalized Medicine, Temple University School of Medicine
Co-authored papers 5
Eduardo Vilar
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Ernest T Hawk
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Chen Hu
Johns Hopkins University School of Medicine
Co-authored papers 4
Massimo A Fazio
Heersink School of Medicine, University of Alabama-Birmingham
Co-authored papers 4
Wenyi Wang
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Mien-Chie Hung
Co-authored papers 3
Brent A Coull
T.H. Chan School of Public Health, Harvard University
Co-authored papers 3
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Shailesh Advani
Co-authored papers 3
Mark J Routbort
University of Texas MD Anderson Cancer Center
Co-authored papers 3
John D Minna
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 2
Ryuji Kobayashi
Tokyo University of Science
Co-authored papers 2
John M Koomen
Co-authored papers 2
Hongtu Zhu
University of North Carolina
Co-authored papers 2
Christopher I Amos
Baylor College of Medicine
Co-authored papers 2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2
Arvind Rao
University of Michigan-Ann Arbor
Co-authored papers 2
Hop S Tran Cao
Co-authored papers 2
Brian C Samuels
University of Alabama at Birmingham
Co-authored papers 2
Min Jin Ha
Co-authored papers 2
Release 1.2